Development and preclinical assessment of a first-in-class small molecule inhibitor of FLIP

被引:0
作者
Majkut, Joanna
Higgins, Catherine
Fox, Jennifer
Fiedler, Greti E.
Harrison, Timothy
Longley, Daniel B.
机构
基金
英国惠康基金;
关键词
D O I
10.1158/1538-7445.AM2017-LB-305
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-305
引用
收藏
页数:2
相关论文
共 50 条
[41]   FDA approves first-in-class SYK inhibitor [J].
Mullard, Asher .
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (06) :385-385
[42]   Rilzabrutinib, the first-in-class BTK inhibitor for ITP [J].
Michel, Marc .
BLOOD, 2023, 145 (24) :2810-2812
[43]   FDA approves first-in-class SYK inhibitor [J].
Asher Mullard .
Nature Reviews Drug Discovery, 2018, 17 :385-385
[44]   Romosozumab: A first-in-class scierostin inhibitor for osteoprosis [J].
Prather, Caitlin ;
Adams, Erin ;
Zentgraf, Whitney .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (23) :1949-1956
[45]   A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives [J].
Gu, Jinying ;
Wu, Qiuyu ;
Zhang, Qiuyue ;
You, Qidong ;
Wang, Lei .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 243
[46]   First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy [J].
Huber, Andrew D. ;
Jung, Young-Hwan ;
Li, Yongtao ;
Lin, Wenwei ;
Wu, Jing ;
Poudel, Shyaron ;
Carrigan, Annalise G. ;
Mishra, Ashutosh ;
High, Anthony A. ;
Chen, Taosheng .
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (20) :18549-18575
[47]   Synergistic effects of RPT1G, a first-in-class small molecule NAMPT inhibitor, with venetoclax and olaparib in hematological malignancies [J].
Crimmins, Gregory ;
Wu, Min ;
Roushar, Francis ;
Bhurruth-Alcor, Yushma ;
Jarvela, Timothy ;
Digel, James ;
Robb, Caroline ;
Moghaddam-Taaheri, Parisa ;
De Jesus-Diaz, Dennise ;
McCormick, Frank .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[48]   Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor [J].
Allaway, Graham P. .
RETROVIROLOGY, 2006, 3 (Suppl 1)
[49]   DEVELOPMENT OF THE FIRST-IN-CLASS INHIBITOR OF CHD4-SENSITIZING RESISTANT GLIOMAS [J].
Nurmemmedov, Elmar ;
Kesari, Santosh .
NEURO-ONCOLOGY, 2020, 22 :63-63
[50]   Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor [J].
Graham P Allaway .
Retrovirology, 3